Overview
Megha Shah is a Hematologist Oncology specialist and a Hematologist in Flemington, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Multiple Carboxylase Deficiency. Her top areas of expertise are Familial Colorectal Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Shah is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2100 Wescott Dr, Flemington, NJ 08822
New York University
Gerard Donnelly is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Donnelly is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Hereditary Resistance to Anti-Vitamin K, Protein C Deficiency, Protein S Deficiency, and Congenital Antithrombin 3 Deficiency.
Montefiore Medical Center
Sandeep Malik is a Hematologist Oncology specialist and an Oncologist in Bronx, New York. Dr. Malik is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Malabsorption, Deep Vein Thrombosis, Essential Thrombocythemia, and Intraductal Papilloma.
Hunterdon Hematology Oncology, LLC
Myron Bednar is a Hematologist Oncology specialist and a Hematologist in Flemington, New Jersey. Dr. Bednar is rated as a Distinguished provider by MediFind in the treatment of Multiple Carboxylase Deficiency. His top areas of expertise are Inflammatory Breast Cancer, Febrile Neutropenia, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Bednar is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Shah isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Shah isDistinguished. Learn about Breast Cancer.
- Familial Colorectal CancerDr. Shah isDistinguished. Learn about Familial Colorectal Cancer.
- Paget Disease of the BreastDr. Shah isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Shah isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- AgranulocytosisDr. Shah isAdvanced. Learn about Agranulocytosis.
- Blood ClotsDr. Shah isAdvanced. Learn about Blood Clots.
- Chronic Familial NeutropeniaDr. Shah isAdvanced. Learn about Chronic Familial Neutropenia.
- Colorectal CancerDr. Shah isAdvanced. Learn about Colorectal Cancer.
- Familial Pancreatic CancerDr. Shah isAdvanced. Learn about Familial Pancreatic Cancer.
- Febrile NeutropeniaDr. Shah isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Shah isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Shah isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Shah isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shah isExperienced. Learn about Acute Myeloid Leukemia (AML).